Literature DB >> 15575992

The prevalence, intensity and clinical signs of urinary schistosomiasis in Imo state, Nigeria.

C G Okoli1, M O E Iwuala.   

Abstract

Urine samples were assayed for urinary schistosomiasis in four local government areas (LGA) of Imo State, Nigeria between May 1998 and September 2000. A total of 3504 persons were sampled, with 880 (25.1%) being positive for urinary schistosomiasis, based on records of eggs of Schistosoma haematobium. The prevalence of S. haematobium infection differed in the various LGAs, with Oguta (38.9%) and Owerri-West (10.4%) showing the highest and the lowest values, respectively. Prevalence was higher in males (67.4%) than in females (32.6%) and in subjects 11-20 years of age (31.5%), while prevalence varied among different occupational groups, with farmers ranking the highest (41.6%). Visible haematuria was the predominant symptom (P<0.05). Of 880 persons positive for eggs of S. haematobium, 452 (51.4%) had visible haematuria, followed by suprapubic pains 214 (24.3%) and painful micturition 97 (11.0%). Although 367 (10. 5%) of the sampled subjects with eggs of S. haematobium showed no visible haematuria, 513 (14.6%) clearly demonstrated haematuria.

Entities:  

Mesh:

Year:  2004        PMID: 15575992     DOI: 10.1079/joh2004251

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  3 in total

1.  Proportion of Urinary Schistosomiasis among HIV-Infected Subjects in Benin City, Nigeria.

Authors:  Akinbo Frederick Olusegun; Okaka Christopher Ehis; Omoregie Richard
Journal:  Oman Med J       Date:  2011-05

2.  Bladder cancer and urinary Schistosomiasis in Angola.

Authors:  Monica C Botelho; Jacinta Figueiredo; Helena Alves
Journal:  J Nephrol Res       Date:  2015-06

3.  Epidemiological dynamics and associated risk factors of S. haematobium in humans and its snail vectors in Nigeria: a meta-analysis (1983-2018).

Authors:  Paul Olalekan Odeniran; Kehinde Foluke Omolabi; Isaiah Oluwafemi Ademola
Journal:  Pathog Glob Health       Date:  2020-03-17       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.